Susquehanna raised the firm’s price target on Accenture (ACN) to $277 from $270 and keeps a Neutral rating on the shares. The firm said despite landing towards the high end of guidance, the outlook remained largely unchanged, and the Book/Bill supports the outlook.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACN:
- Accenture price target raised to $320 from $315 at UBS
- Accenture: Resilient Execution, AI-Driven Growth, and Margin Durability Support Buy Rating Despite Share Weakness
- Accenture Earnings Call Highlights AI-Led Growth Momentum
- Accenture to explore partnerships with DOE to support Genesis Mission
- Accenture price target raised to $300 from $280 at Evercore ISI